Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma
Crossref DOI link: https://doi.org/10.1007/s00259-017-3771-8
Published Online: 2017-07-14
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Adams, Hugo J. A. http://orcid.org/0000-0003-1049-7607
Kwee, Thomas C.
License valid from 2017-07-14